Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry.

The stoichiometry of protein phosphorylation at specific amino acid sites may be used to infer on the significance of the modification, and its biological function in the cell. However, detection and quantification of phosphorylation stoichiometry in tissue remain a significant challenge. Here we describe a strategy for highly sensitive, label-free quantification of protein phosphorylation stoichiometry. Method development included the analysis of synthetic peptides in order to determine constants to relate the mass spectrometry signals of cognate peptide/phosphopeptide pairs, and the detection of the cognate peptides by using high resolution Fourier Transform mass spectrometry (FTMS) and selected reaction monitoring mass spectrometry (SRM). By analyzing extracted ion currents by FTMS, the phosphorylation stoichiometries of two tyrosine residues (tyrosine-194 and tyrosine-397) in the protein tyrosine kinase Lyn were determined in transfected human HEK293T cells and two cultured human multiple myeloma strains. To achieve high sensitivity to measure phosphorylation stoichiometry in tissue, SRM methods were developed and applied for the analysis of phosphorylation stoichiometries of Lyn phospho-sites in multiple myeloma xenograft tumors. Western immuno-blotting was used to verify mass spectrometry findings. The SRM method has potential applications in analyzing clinical samples wherein protein phosphorylation stoichiometries may represent important pharmacodynamic biomarkers.

[1]  M. Olivier,et al.  Relative quantification of peptide phosphorylation in a complex mixture using 18O labeling. , 2007, Physiological genomics.

[2]  Hanno Steen,et al.  Different phosphorylation states of the anaphase promoting complex in response to antimitotic drugs: A quantitative proteomic analysis , 2008, Proceedings of the National Academy of Sciences.

[3]  M. Larsen,et al.  Analytical strategies for phosphoproteomics , 2009, Expert review of neurotherapeutics.

[4]  R. Nirogi,et al.  Simultaneous quantification of cilostazol and its primary metabolite 3,4-dehydrocilostazol in human plasma by rapid liquid chromatography/tandem mass spectrometry , 2006, Analytical and bioanalytical chemistry.

[5]  J. Kuriyan,et al.  Structures of Src-family tyrosine kinases. , 1997, Current opinion in structural biology.

[6]  M. Moran,et al.  Epidermal Growth Factor Receptor Phosphorylation Sites Ser991 and Tyr998 Are Implicated in the Regulation of Receptor Endocytosis and Phosphorylations at Ser1039 and Thr1041* , 2009, Molecular & Cellular Proteomics.

[7]  Robertson Craig,et al.  TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.

[8]  M. Kirschner,et al.  Stable isotope-free relative and absolute quantitation of protein phosphorylation stoichiometry by MS. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Hallek,et al.  Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines. , 1997, Experimental hematology.

[10]  P. L. Bergsagel,et al.  Inhibition of fibroblast growth factor receptor 3 induces differentiation and apoptosis in t(4;14) myeloma. , 2004, Blood.

[11]  Paul Tempst,et al.  A Prototype Antibody Microarray Platform to Monitor Changes in Protein Tyrosine Phosphorylation* , 2004, Molecular & Cellular Proteomics.

[12]  J. Rush,et al.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells , 2005, Nature Biotechnology.

[13]  M. Moran,et al.  Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor. , 2008, Journal of proteome research.

[14]  Gennifer E. Merrihew,et al.  Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development. , 2009, Journal of proteome research.

[15]  S. Hanks,et al.  Absolute quantification of phosphorylation on the kinase activation loop of cellular focal adhesion kinase by stable isotope dilution liquid chromatography/mass spectrometry. , 2009, Analytical chemistry.

[16]  M. Hibbs,et al.  Lyn tyrosine kinase: accentuating the positive and the negative. , 2005, Immunity.

[17]  Hanno Steen,et al.  Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. , 2002, Trends in biotechnology.

[18]  J. Sass,et al.  Comprehensive detection of disorders of purine and pyrimidine metabolism by HPLC with electrospray ionization tandem mass spectrometry. , 2006, Clinical chemistry.

[19]  Hanno Steen,et al.  Phosphorylation Analysis by Mass Spectrometry , 2006, Molecular & Cellular Proteomics.

[20]  Ying-wu Wang,et al.  Liquid chromatography tandem mass spectrometry assay to determine the pharmacokinetics of aildenafil in human plasma. , 2007, Journal of pharmaceutical and biomedical analysis.

[21]  Wolfram Weckwerth,et al.  Differential Multisite Phosphorylation of the Trehalose-6-phosphate Synthase Gene Family in Arabidopsis thaliana , 2005, Molecular & Cellular Proteomics.

[22]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[23]  N. Gray,et al.  Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.

[24]  Lukas N. Mueller,et al.  An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. , 2008, Journal of proteome research.

[25]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[26]  M. Moran,et al.  Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts , 2004, Clinical Proteomics.

[27]  Lukas N. Mueller,et al.  SuperHirn – a novel tool for high resolution LC‐MS‐based peptide/protein profiling , 2007, Proteomics.

[28]  Paul Taylor,et al.  Emerging applications for phospho-proteomics in cancer molecular therapeutics. , 2006, Biochimica et biophysica acta.

[29]  Linfeng Wu,et al.  Absolute Quantification of Multisite Phosphorylation by Selective Reaction Monitoring Mass Spectrometry , 2006, Molecular & Cellular Proteomics.

[30]  M. Mann,et al.  Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks , 2006, Cell.

[31]  M. Mann,et al.  Global and site-specific quantitative phosphoproteomics: principles and applications. , 2009, Annual review of pharmacology and toxicology.

[32]  Guanghui Wang,et al.  Label-free protein quantification using LC-coupled ion trap or FT mass spectrometry: Reproducibility, linearity, and application with complex proteomes. , 2006, Journal of proteome research.

[33]  Kerry G Bemis,et al.  Label-free mass spectrometry-based protein quantification technologies in proteomic analysis. , 2008, Briefings in functional genomics & proteomics.

[34]  Mathieu Courcelles,et al.  Combined Enzymatic and Data Mining Approaches for Comprehensive Phosphoproteome Analyses , 2008, Molecular & Cellular Proteomics.

[35]  P. Furet,et al.  Modulation of the SH2 Binding Specificity and Kinase Activity of Src by Tyrosine Phosphorylation within Its SH2 Domain (*) , 1996, The Journal of Biological Chemistry.

[36]  D. Lauffenburger,et al.  Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks , 2007, Proceedings of the National Academy of Sciences.

[37]  D. Metcalfe,et al.  Determination of protein phosphorylation in Fc epsilon RI-activated human mast cells by immunoblot analysis requires protein extraction under denaturing conditions. , 2002, Journal of immunological methods.